middle.news
How Vitrafy’s IMV Deal and U.S. Expansion Could Transform Cryopreservation Markets
8:36am on Wednesday 4th of February, 2026 AEDT
•
Healthcare
Read Story
How Vitrafy’s IMV Deal and U.S. Expansion Could Transform Cryopreservation Markets
8:36am on Wednesday 4th of February, 2026 AEDT
Key Points
Strategic 12-month commercial agreement with IMV Technologies in animal health
Phase 2 blood platelet freezing study underway with U.S. Military collaboration
First Guardion cryopreservation device deployed in the U.S. and FDA registration commenced
Strong cash reserves of $22.8 million with runway through calendar 2027
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Vitrafy Life Sciences (ASX:VFY)
OPEN ARTICLE